Genetics of Tissue Remodelling
Tissue remodelling involves the dynamic turnover of extracellular matrix proteins and is governed by matrix metalloproteinases (MMPs) and their inhibitors (TIMPs). Genetic variants in these genes may influence fibrotic responses, tissue repair efficiency, and chronic illness progression.
This page is for educational and informational purposes only. Not a diagnostic tool. Always consult a qualified healthcare provider.
What is Tissue Remodelling?
Extracellular matrix (ECM) remodelling is essential for wound healing, organ maintenance, and immune cell migration. Dysregulation of this process contributes to fibrosis, impaired tissue repair, and chronic inflammation. MMP genes (MMP1, MMP2, MMP3, MMP9) degrade ECM components, while TIMPs regulate their activity. In Long COVID, aberrant tissue remodelling has been implicated in lung fibrosis, vascular damage, and persistent inflammation. Genetic variation in MMP and collagen synthesis genes may affect the balance between repair and pathological remodelling.
Biological pathways commonly discussed in relation to Tissue Remodelling
Research into Extracellular Matrix Remodelling and Tissue Repair has highlighted several biological pathways that may be relevant. Genetic variants within these pathways may influence individual susceptibility, symptom severity, or the trajectory of the condition.
Matrix Metalloproteinase
MMPs are zinc-dependent endopeptidases that degrade ECM proteins. Variants in MMP1, MMP3, and MMP9 promoters affecting expression levels have been associated with inflammatory and fibrotic conditions.
Collagen Synthesis
Collagen genes (COL1A1, COL3A1, COL5A1) encode structural ECM proteins. Variants affecting collagen quality or quantity may influence joint laxity, vascular fragility, and tissue integrity.
Fibrosis
Profibrotic signalling via TGF-beta (TGFB1) drives fibroblast activation and excess ECM deposition. TGFB1 variants modulating expression levels have been studied in pulmonary fibrosis, liver fibrosis, and inflammatory conditions.
Wound Healing
Wound healing requires coordinated ECM remodelling, angiogenesis, and immune resolution. Variants in VEGFA, PDGFB, and ECM genes may influence healing efficiency and scarring outcomes.
Key genes studied in relation to Tissue Remodelling
The following genes have been studied in relation to Extracellular Matrix Remodelling and Tissue Repair. These genes span the biological pathways most commonly discussed in this area of research.
Genetic variants commonly discussed
The following genetic variants (SNPs) are found in genes that have been studied in relation to Tissue Remodelling. Each variant represents a position in the genome where individuals may carry different alleles.
9 variants total across genes studied in relation to Tissue Remodelling.
How personal DNA data may provide educational insights
Consumer DNA files from 23andMe, AncestryDNA, and MyHeritage contain raw SNP data. When you upload your file to ChronicDNA, the analysis engine checks your genotype against a curated panel of 80+ genes selected for their relevance to Long COVID, ME/CFS, and connected biological pathways - some of which may relate to areas such as Tissue Remodelling.
This is not a diagnostic service. Genetic variants do not determine whether you have Tissue Remodelling, nor do they predict your clinical outcomes. The report is educational - it explains which variants you carry, what the research says about them, and how they fit into the biological pathways most relevant to chronic illness. All results should be discussed with a qualified healthcare provider.
Related conditions and pathways
Tissue Remodelling shares biological pathways and genetic associations with the following related conditions and areas of research.
Frequently asked questions
How does tissue remodelling relate to Long COVID?
Long COVID patients have shown evidence of lung fibrosis, vascular remodelling, and persistent inflammatory tissue changes. Genetic variants in MMP and TGF-beta pathway genes may influence the extent of tissue remodelling following SARS-CoV-2 infection and the efficiency of recovery.
What are MMPs and why are their genetics relevant?
Matrix metalloproteinases (MMPs) are enzymes that break down extracellular matrix components. Promoter variants in MMP1, MMP3, and MMP9 affect transcription levels and have been associated with inflammatory, cardiovascular, and fibrotic conditions. Their activity is balanced by TIMP inhibitors.
Which tissue remodelling genes are studied in chronic illness?
Key genes include MMP1, MMP2, MMP3, MMP9, TIMP1, TIMP2, TGFB1, COL1A1, COL3A1, and VEGFA. Together these cover ECM degradation, fibrosis signalling, collagen quality, and angiogenic repair.
Can genetics predict fibrosis risk after COVID-19?
Genetic variants in TGFB1 and MMP genes may modulate fibrotic responses after lung injury, including COVID-19 pneumonia. This is an active research area. ChronicDNA analyses these variants for educational purposes — clinical fibrosis assessment requires imaging and specialist evaluation.
Explore DNA insights
If you already have DNA data from 23andMe, AncestryDNA, or MyHeritage, upload your raw file to ChronicDNA and receive a personalised educational report covering genes studied in relation to Tissue Remodelling and connected biological pathways.
Get Your Personalised DNA ReportInformational and educational only · Not a diagnostic tool · GDPR compliant
6 genes · 9 variants analysed in relation to Tissue Remodelling